Copyright Reports & Markets. All rights reserved.

Global Isocitrate Dehydrogenase Inhibitors Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Isocitrate Dehydrogenase Inhibitors Market Status and Forecast (2017-2028)
      • 1.3.2 Global Isocitrate Dehydrogenase Inhibitors Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Isocitrate Dehydrogenase Inhibitors Supply by Company

    • 2.1 Global Isocitrate Dehydrogenase Inhibitors Sales Value by Company
    • 2.2 Isocitrate Dehydrogenase Inhibitors Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Isocitrate Dehydrogenase Inhibitors Market Status by Type

    • 3.1 Isocitrate Dehydrogenase Inhibitors Type Introduction
      • 3.1.1 IDH1 Mutant Medullary Malignant Tumor
      • 3.1.2 IDH2 Mutant Medullary Malignant Tumor
      • 3.1.3 Others
    • 3.2 Global Isocitrate Dehydrogenase Inhibitors Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Isocitrate Dehydrogenase Inhibitors Market Status by Application

    • 4.1 Isocitrate Dehydrogenase Inhibitors Segment by Application
      • 4.1.1 DH Inhibitor
      • 4.1.2 FLT3 Inhibitor
      • 4.1.3 Hedgehog Pathway Inhibitor
      • 4.1.4 Others
    • 4.2 Global Isocitrate Dehydrogenase Inhibitors Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Isocitrate Dehydrogenase Inhibitors Market Status by Region

    • 5.1 Global Isocitrate Dehydrogenase Inhibitors Market by Region
    • 5.2 North America Isocitrate Dehydrogenase Inhibitors Market Status
    • 5.3 Europe Isocitrate Dehydrogenase Inhibitors Market Status
    • 5.4 Asia Pacific Isocitrate Dehydrogenase Inhibitors Market Status
    • 5.5 Central & South America Isocitrate Dehydrogenase Inhibitors Market Status
    • 5.6 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Status

    6 North America Isocitrate Dehydrogenase Inhibitors Market Status

    • 6.1 North America Isocitrate Dehydrogenase Inhibitors Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Isocitrate Dehydrogenase Inhibitors Market Status

    • 7.1 Europe Isocitrate Dehydrogenase Inhibitors Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Isocitrate Dehydrogenase Inhibitors Market Status

    • 8.1 Asia Pacific Isocitrate Dehydrogenase Inhibitors Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Isocitrate Dehydrogenase Inhibitors Market Status

    • 9.1 Central & South America Isocitrate Dehydrogenase Inhibitors Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Status

    • 10.1 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Isocitrate Dehydrogenase Inhibitors Market Forecast by Type and by Application

    • 12.1 Global Isocitrate Dehydrogenase Inhibitors Sales Value Forecast (2023-2028)
    • 12.2 Global Isocitrate Dehydrogenase Inhibitors Forecast by Type
    • 12.3 Global Isocitrate Dehydrogenase Inhibitors Forecast by Application

    13 Global Isocitrate Dehydrogenase Inhibitors Market Forecast by Region/Country

    • 13.1 Global Isocitrate Dehydrogenase Inhibitors Market Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 AGIOS
      • 14.1.1 Company Information
      • 14.1.2 Isocitrate Dehydrogenase Inhibitors Product Introduction
      • 14.1.3 AGIOS Isocitrate Dehydrogenase Inhibitors Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Tragara/Adastra
      • 14.2.1 Company Information
      • 14.2.2 Isocitrate Dehydrogenase Inhibitors Product Introduction
      • 14.2.3 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Tocagen
      • 14.3.1 Company Information
      • 14.3.2 Isocitrate Dehydrogenase Inhibitors Product Introduction
      • 14.3.3 Tocagen Isocitrate Dehydrogenase Inhibitors Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Tesaro
      • 14.4.1 Company Information
      • 14.4.2 Isocitrate Dehydrogenase Inhibitors Product Introduction
      • 14.4.3 Tesaro Isocitrate Dehydrogenase Inhibitors Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Philogen S.p.A.
      • 14.5.1 Company Information
      • 14.5.2 Isocitrate Dehydrogenase Inhibitors Product Introduction
      • 14.5.3 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 Daiichi Sankyo
      • 14.6.1 Company Information
      • 14.6.2 Isocitrate Dehydrogenase Inhibitors Product Introduction
      • 14.6.3 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 Celgene
      • 14.7.1 Company Information
      • 14.7.2 Isocitrate Dehydrogenase Inhibitors Product Introduction
      • 14.7.3 Celgene Isocitrate Dehydrogenase Inhibitors Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Bristol-Myers Squibb
      • 14.8.1 Company Information
      • 14.8.2 Isocitrate Dehydrogenase Inhibitors Product Introduction
      • 14.8.3 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Beigene
      • 14.9.1 Company Information
      • 14.9.2 Isocitrate Dehydrogenase Inhibitors Product Introduction
      • 14.9.3 Beigene Isocitrate Dehydrogenase Inhibitors Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 Bayer
      • 14.10.1 Company Information
      • 14.10.2 Isocitrate Dehydrogenase Inhibitors Product Introduction
      • 14.10.3 Bayer Isocitrate Dehydrogenase Inhibitors Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 Aslan Pharmaceuticals

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Isocitrate Dehydrogenase Inhibitors market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Isocitrate Dehydrogenase Inhibitors industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Isocitrate Dehydrogenase Inhibitors market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Isocitrate Dehydrogenase Inhibitors Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Isocitrate Dehydrogenase Inhibitors market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Isocitrate Dehydrogenase Inhibitors Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Isocitrate Dehydrogenase Inhibitors industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      IDH1 Mutant Medullary Malignant Tumor
      IDH2 Mutant Medullary Malignant Tumor
      Others

      Segmented by Application
      DH Inhibitor
      FLT3 Inhibitor
      Hedgehog Pathway Inhibitor
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      AGIOS
      Tragara/Adastra
      Tocagen
      Tesaro
      Philogen S.p.A.
      Daiichi Sankyo
      Celgene
      Bristol-Myers Squibb
      Beigene
      Bayer
      Aslan Pharmaceuticals
      Buy now